eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.72+0.20 (+3.62%)

Delayed quote: Oct 6, 2026, 10:57 AM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T15:06:35.422Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:06:35.422Z.

Quote observation: 2026-10-06T14:57:26.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -6,995,227
Quote market capitalization: 53,089,373

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

EXOZ Competitors' Operating Cash Flow Yield

EXOZ

eXoZymes, Inc.

Current

Market Cap

$53.09M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$51.61M

Operating Cash Flow Yield

47.22%

TTM Avg

50.32%

3Y Avg

31.17%

5Y Avg

36.60%

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$52.13M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$52.54M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$54.25M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$51.33M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$51.01M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs EXOZ

Market Cap

$51.05M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs EXOZ

Market Cap

$55.53M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs EXOZ

Market Cap

$49.93M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$53.09M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	47.22%	50.32%	31.17%	36.60%
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.13M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.54M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$54.25M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$51.01M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$51.05M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$55.53M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$49.93M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

EXOZ Operating Cash Flow Yield Metrics

EXOZ Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics